Incorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells
Yifei Zhang,1,* Yixian Huang,1,* Peng Zhang,1 Xiang Gao,1 Robert B Gibbs,2 Song Li1 1Center for Pharmacogenetics, 2Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA*These authors contributed equally to this workBackground: The sigma-2 receptor is...
Guardado en:
Autores principales: | Zhang Y, Huang Y, Zhang P, Gao X, Gibbs RB, Li S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cf5aca379f504701bfb7c256f4494485 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects
por: Song Z, et al.
Publicado: (2017) -
Modulated electro-hyperthermia-enhanced liposomal drug uptake by cancer cells
por: Tsang YW, et al.
Publicado: (2019) -
Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption
por: Juan Guan, et al.
Publicado: (2018) -
Modulated electro-hyperthermia-enhanced liposomal drug uptake by cancer cells [Corrigendum]
por: Tsang YW, et al.
Publicado: (2019) -
Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells
por: David A. Ostrov, et al.
Publicado: (2021)